How to stomach an epigenetic insult: the gastric cancer epigenome

N Padmanabhan, T Ushijima, P Tan - Nature reviews Gastroenterology …, 2017 - nature.com
Gastric cancer is a deadly malignancy afflicting close to a million people worldwide. Patient
survival is poor and largely due to late diagnosis and suboptimal therapies. Disease …

The role of RASSF1A methylation in cancer

LB Hesson, WN Cooper, F Latif - Disease markers, 2007 - content.iospress.com
Tumour suppressor gene inactivation is critical to the pathogenesis of cancers; such loss of
function may be mediated by irreversible processes such as gene deletion or mutation …

[HTML][HTML] The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice

F Graziano, B Humar, P Guilford - Annals of oncology, 2003 - Elsevier
Loss of function of the E-cadherin gene (CDH1) has been linked with diffuse gastric cancer
susceptibility, and germline inactivating mutations in CDH1 characterise the hereditary …

[HTML][HTML] Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer

G Tamura - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
The development and progression of gastric cancer involves a number of genetic and
epigenetic alterations of tumor suppressor and tumor-related genes. The majority of …

Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation

GH Kang, HJ Lee, KS Hwang, S Lee, JH Kim… - The American journal of …, 2003 - Elsevier
Aberrant hypermethylation of promoter CpG islands is an important mechanism for the
inactivation of tumor suppressor genes. CpG island hypermethylation occurs in relation to …

Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?

T Nakajima, I Oda, T Gotoda, H Hamanaka, T Eguchi… - Gastric cancer, 2006 - Springer
Background Endoscopic resection (ER) has been widely accepted in Japan as a less
invasive treatment for early gastric cancer, but the incidence of subsequent metachronous …

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer

J Yu, YY Cheng, Q Tao, KF Cheung, CNY Lam, H Geng… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: By using methylation-sensitive representational difference
analysis, we identified protocadherin 10 (PCDH10), a gene that encodes a protocadherin …

Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples

T Waki, G Tamura, M Sato, T Motoyama - Oncogene, 2003 - nature.com
Age-related methylation may have the potential to behave as a mutator process. To clarify
the physiological consequence of age-related methylation of tumor suppressor and tumor …

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk

CM Lewis, LR Cler, DW Bu… - Clinical Cancer …, 2005 - AACR
Introduction: The tumor suppressor genes RASSF1A, APC, H-cadherin, RARβ2, and cyclin
D2 are methylated more frequently in breast cancer than in adjacent benign tissue …

Pathology and molecular biology of gastric cancer

M Vauhkonen, H Vauhkonen, P Sipponen - Best Practice & Research …, 2006 - Elsevier
Several attempts to classify gastric cancer (GCA) have been made over the past decades.
Most successful, and widely used, is the classification by Laurén, which distinguishes, by …